Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Articles by Staff

Carpal Tunnel Syndrome

  |  

Carpal tunnel syndrome (CTS) is possibly the most common nerve disorder experienced today. It affects 3% to 7% of the population and is usually treatable. Middle-age and older individuals are more likely to develop CTS than younger people, and women develop CTS three times more frequently than men.

Become a Champion for RA

  |  

Ask any rheumatologist about the state of RA as a disease and you’re likely to get the same answer: There’s reason for great optimism and there’s a lot of work to be done.

Fraud and Abuse: What’s the Difference?

  |  

Each year, fraud and abuse cost the Medicare and Medicaid programs billions of dollars. What is the difference between fraud and abuse? The Centers for Medicare & Medicaid Services define fraud and abuse as two different offenses…

National HMO Class-Action Case Settled

  |  

The latest development in the healthcare class-action settlement will affect approximately 900,000 physicians (and some major state medical societies) who may be eligible to receive compensation from the settlement – as long as they file a claim. The case has been called “historic” by those representing both physicians and insurance companies.

Voices on the Hill

  |  

On September 19, the ACR and the Arthritis Foundation held a joint legislative briefing to inform Congress members and their staff about the devastating effects of arthritis and related rheumatic diseases, as well as to encourage support of the “Arthritis Prevention, Control, and Cure Act of 2007” (S.626/H.R. 1283), or Arthritis Act.

Birthday in Bean Town

David S. Pisetsky, MD, PhD  |  

As TR celebrates one year, we look forward to an exciting 2008

A Golden Anniversary

Jane Jerrard  |  

Arthritis & Rheumatism Celebrates Its 50th Year

Pursue Remission

Carol A. Wallace, MD  |  

Disease remission should be the goal for all rheumatologists treating childhood arthritis